FDA Roundup: October 15, 2024
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: — Today, the FDA’s Center for Drug Evaluation and Research (CDER) released the 2024 Accelerating Rare disease Cures (ARC) ProgramAnnual Report. Since its launch in 2022, CDER’s ARC Program has become a key resource for the rare […]